395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM™) adoptive cell therapy (ACT) T cells
oleh: Rui Wang, Adam Parks, Mathias Oelke, Shweta Jain, Ruipeng Wang, Sojung Kim, Jack Ragheb, Charles Reed, Brian Alvarez, Jerome Zeldis, Daniel Bednarik
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.